SBIR Topic 158 addresses the demand to promote awareness and knowledge of the best practice in management of Neonatal Abstinence Syndrome (NAS). The need is caused by clinical rigor and raised concerns among neonatal and pediatric practitioners regarding a constellation of various withdrawal symptoms and treatment approaches. The ultimate goal of this contract is to develop a skill-building Primer and Reference Tool to assist clinicians in identifying, interpretation, scoring and responding to NAS symptoms toward improving neonatal outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Business Innovation Research – Phase I (N43)
Project #
271201600019C-0-0-1
Application #
9369132
Study Section
Project Start
2016-09-01
Project End
2017-03-03
Budget Start
Budget End
Support Year
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Benten Technologies, Inc.
Department
Type
DUNS #
048027119
City
Chantilly
State
VA
Country
United States
Zip Code
20151